AVERY CATLIN - 17 May 2022 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role
Director
Signature
/s/ Thierry Chauche, as attorney-in-fact
Issuer symbol
PRVB
Transactions as of
17 May 2022
Transactions value $
$0
Form type
4
Filing time
18 May 2022, 18:04:43 UTC
Previous filing
17 Jun 2021
Next filing
19 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Award $0 +33,000 $0.000000 33,000 17 May 2022 Common Stock, par value $0.0001 33,000 $4.52 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in full and become exercisable upon the earlier to occur of (a) the business day before the Issuer's next annual meeting of stockholders and (b) May 17, 2023.
F2 The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.

Remarks:

Exhibit 24.1 - Power of Attorney